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Amyloid plaques consisting of aggregated Ab peptide are a
hallmark of Alzheimer’s disease. Among the different forms
of Ab, the one of 42aa length (Ab42) is most aggregation-
prone and also the most neurotoxic. We find that eye-specific
expression of human Ab42 in Drosophila results in a degen-
eration of eye structures that progresses with age. Dietary
supplements of zinc or copper ions exacerbate eye damage.
Positive effects are seen with zinc/copper chelators, or with
elevated expression of MTF-1, a transcription factor with a
key role in metal homeostasis and detoxification, or with
human or fly transgenes encoding metallothioneins, metal
scavenger proteins. These results show that a tight control of
zinc and copper availability can minimize cellular damage
associated with Ab42 expression.
Keywords: Alzheimer’s disease; amyloid-b protein;
copper; heavy metal stress; MTF-1; zinc.
Alzheimer’s disease (AD) is a neurodegenerative disorder
characterized by amyloid plaques and neurofibrillary tangles
in the brain. The main component of amyloid plaques, amy-
loid b peptide (Ab), is widely regarded as the primary culprit
in Alzheimer’s disease (Selkoe, 2001). Ab occurs in various
lengths, whereby Ab42 is the most aggregation-prone and
also the most neurotoxic form (Simmons et al., 1994; Gong
et al., 2003; Hsieh et al., 2006; Shankar et al., 2007; Selkoe,
2008; Harmeier et al., 2009). The monomeric form of Ab is
not toxic (Selkoe, 2008) or at least less toxic than aggregated
low-n multimers (Kayed et al., 2003; Selkoe, 2008; Harmeier
et al., 2009). Amyloid plaques are highly enriched for zinc,
copper and iron ions (Lovell et al., 1998), and histidines at
positions 6, 13 and 14 of Ab were shown to bind Zn(II) and
Cu(II) (Atwood et al., 2000; Danielsson et al., 2007). Cell-
free studies have revealed that binding of Cu(II) or Zn(II)
promotes the aggregation of synthetic Ab (Atwood et al.,
1998; Bush et al., 1994). Also, metal chelators can dissolve
the Ab plaques from postmortem AD brains (Cherny et al.,
1999). Ab-copper complexes were shown in vitro to gener-
ate reactive oxygen species (ROS) via a Fenton-like reaction
(Huang et al., 1999). The fact that Ab42 in this assay has a
higher propensity to generate ROS than Ab40 could, at least
in part, explain why Ab42 is more neurotoxic and would
suggest a role for redox-active metals such as copper and
iron in this process. However, AD patients were found to
have decreased copper levels in the cortex (Maurer et al.,
2000; Cottrell et al., 2001) and in a mouse model of AD,
copper supplementation reduced amyloid plaque formation
and increased the activity of the antioxidant enzyme Cu/Zn
SOD (Bayer et al., 2003).
In recent years, Drosophila models for Alzheimer’s dis-
ease were developed (Finelli et al., 2004; Greeve et al., 2004;
Crowther et al., 2005), and several factors (such as insulin-
degrading enzyme, apolipoprotein E, oxidative stress) known
to be related to Alzheimer’s disease were studied with these
Drosophila models (Rival et al., 2009; Sarantseva et al.,
2009; Sofola et al., 2010; Tsuda et al., 2010; Ling and Sal-
vaterra, 2011). Work from these groups has shown that Dro-
sophila recapitulates several pathological features also seen
in Alzheimer’s disease. Based on this knowledge we gener-
ated a Drosophila model for AD to test various genetic and
environmental factors that might affect the toxicity of Ab42.
To this end, we made transgenic flies expressing human
Ab42. Peptide expression levels and signal peptide process-
ing were verified by Western blot and mass spectrometry
(Figure 1C). Ab42 expressed under the control of an eye-
specific driver (GMR-Gal4) caused a degeneration of eye
structure. The severity of the eye phenotype correlated with
the Ab42 expression level and the age of the flies, i.e., when
the expression level was higher or the flies grew older, eye
malformations were more pronounced (Figure 2). The effect
of zinc and copper ions on Ab42 toxicity was tested by
raising or maintaining flies in food enriched for these essen-
tial metals. Based on previous experiments, 4 mM zinc or
500 mM copper were chosen. These concentrations, which
are relatively high but still tolerated by the standard fly strain
(yw), consistently enhanced the eye distortion phenotype
(Figure 3C, D). To find out whether the effect of zinc and
copper on Ab42 toxicity was direct or indirect, the three
histidines in Ab’s copper/zinc binding site (positions 6, 13
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Figure 1 Expression of Ab42 in Drosophila.
(A) Western blot with Ab-specific antibody to detect Ab42 in trans-
genic fly strains. Ab42 peptides were extracted from transgenic fly
lines with moderate or high Ab42 expression levels (Ab42-medium
and Ab42-high). The N-terminal signal peptide is correctly pro-
cessed because it runs at the same position as the one from flies
expressing Ab42 without signal peptide, as evident from transgenic
line Ab42-no-SP and the synthetic Ab42 controls (arrow). (B) Mass
spectrometry of protein extract from UAS-Ab42-high/q; GMR-
Gal4/q flies. In accordance with the Western blot in (A), the molec-
ular weight of the peak peptide corresponds to Ab42 without signal
peptide.
Methods: flies were raised at 258C and 65% humidity in standard
food containing, per liter, 55 g corn, 10 g wheat, 100 g yeast, 75 g
glucose, 8 g agar, and 15 ml anti-fungal agent nipagin (15% in
ethanol, m/v). The Ab42 coding sequence with the signal peptide
sequence of the Drosophila hedgehog protein was cloned into the
P element transformation vector pUAST. The sequence of Ab42
with the signal peptide is: mdnhssvpwasaasvtclsldakchssssssssks
aassisaipqeetqtmrhiahtqrclsrltslvalllivlpmvfspahsDAEFRHDSGYE
VHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA, whereby lower
case and capital letters denote signal peptide and Ab42 sequences,
respectively. To obtain strains UAS-Ab42-high, UAS-Ab42-medium,
and UAS-hMT3, flies were transformed by standard P element
transposition. Flies expressing Ab42 without signal peptide (UAS-
Ab42-no-SP) were generated in the same manner. The phage C31
site-specific integration system was used to introduce sequences
coding for Ab42, or mutant Ab42 with three histidines (His 6, 13
and 14 of the metal binding site) were changed into arginines. Wild
type and mutant Ab42 were cloned into an attB vector containing
the 5xUAS enhancer/promoter and introduced into the specific attP
‘landing site’ of strain ZH-86Fb, resulting in transgenic flies UAS-
Ab-attB and UAS-Ab-3HR-attB. To direct Ab42 expression to the
nerve system, the Gal4 driver was expressed from the elav enhancer/
promoter, obtained from the Bloomington Stock Center.
Protein was isolated from control flies and Ab42 expressing flies
with RIPA buffer (50 mM Tris-HCl/0.5% sodium deoxycholate/1%
NP-40/150 mM sodium cloride/1% SDS). Sepharose G beads were
preincubated with WO-2 antibody directed against Ab before being
used for immunoprecipitation of Ab peptides from the protein lys-
ate. After immunoprecipitation, samples were loaded on a Novex
10%–20% Tricine gradient gel. For Maldi-MS, after immunopre-
cipitation, samples were washed twice with PBS and then washed
twice with 50% ammonium acetate. Elution was done with 25%
ammonium hydroxide. Maldi-MS was performed as previously
described (Harmeier et al., 2009).
and 14) were replaced by arginines. Expression of such
mutant Ab42 caused only a mild eye degeneration, which
could not be exacerbated by zinc supplement (Figure 3G, H).
One might argue that the milder phenotype was merely due
to a lower expression level. We cannot exclude this but con-
sider it unlikely for two reasons. First, thanks to site-specific
integration, both wild type and mutant(s) were inserted at the
same chromosomal locus and driven by the same promoter,
thereby eliminating differences due to chromosomal position
effects. Second, the phenotype of the mutant was unaffected
by zinc supplement, which argues for a specific and direct
metal effect on Ab42.
Systemic expression of Ab42 under the control of a ubiq-
uitous driver (actin-Gal4) decreased the overall survival rate
of the flies (Figure 4A). Viability was further reduced by
zinc supplement, but not by copper supplement or copper
depletion, indicating that from the two metals, a body-wide
surplus of zinc has more severe consequences. To further test
the effect of metal concentration, we supplemented the food
with metal chelators, notably DP-109 and DP-460 of the
family of ‘membrane-activated chelators’ (MACs). By
attaching to the cell membrane, MACs avoid the problems
that could be caused by a general chelation of metals, and
they were shown to reduce amyloid pathology in Tg2576
mice (Lee et al., 2004; Kolusheva et al., 2005; see also Petri
et al., 2007). Indeed we found that DP-109, a zinc/copper
chelator, increased the fraction of Ab42-expressing flies
developing to adulthood (Figure 4A).
With eye-specific Ab42 expression, eye damage was exac-
erbated by both zinc and copper supplement but ameliorated
by DP-109 or BCS administration (Figure 4B–E). In control
flies not expressing Ab42, normal eye structure was not
affected by copper or zinc treatment (data not shown). When
the expression of Ab42 was directed to the nerve system by
using a neuron-specific driver (elav-Gal4) the flies exhibited
defects in locomotion which were more severe upon zinc
supplementation, as measured by a standard climbing assay:
the number of control flies able to climb the vertical distance
within a given time fell from 100% at day 1 to 92% at day
5 to 72% at day 10. At the same time, the number of suc-
cessful flies on food with 4 mM zinc fell dramatically from
80% to 33% to 3%. Under these latter conditions, there was
a strong rescue effect with a MAC-type chelator (Figure 4F).
The results with mice mentioned above and our own ones
indicate that MACs can efficiently counteract the deleterious
effects of metals in conjunction with Ab. Of note, upon sys-
temic expression of Ab42, DP-109 was effective in the sur-
vival assay whereas the copper-specific chelator BCS was
ineffective. This suggests that DP109’s major role under this
condition was the chelation of zinc.
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Figure 2 Ab42 expression in the eye causes progressive eye
degeneration correlated with age and expression levels.
While the solid surface of the complex eyes remained largely intact,
sections revealed a progressive decay of ommatidial organization in
Ab42-expressing vs. control flies: controls expressing only the
GMR-Gal4 driver maintained normal structures either in young
(1-day) (A) and old (30-day) flies (B) Ab-dependent eye degener-
ation was more severe in 30-day-old flies (D) than in 1-day-old flies
(C). (E) and (F) show eye sections of 5-day-old flies expressing
Ab42 either moderately (UAS-Ab-medium/q; GMR-Gal4/q), or at
high level (UAS-Ab-high/q; GMR-Gal4/q).
Methods: unless specified otherwise, adult flies were collected at
5 days of age and eye sections were analyzed with a Leica Leitz
DMRB fluorescence stereomicroscope (Leica, Wetzlar, Germany).
Note that complex eyes were not always cut at the very same level,
hence even the contours of intact ommatidia may show some var-
iation in this and the following Figures; nevertheless, a distorted
ommatidial structure was always evident irrespective of the plane
of section.
Figure 3 Zinc or copper food supplement exacerbates eye
distortion.
Adult flies that had been kept in different food for 5 days after
eclosure from the puparium were collected and eye sections ana-
lyzed as described in Figure 2. These include control flies (GMR-
Gal4/q) grown on standard food (NF) (A) or flies expressing Ab42
in the eyes (UAS-AbS3/q; GMR-Gal4/q), also grown on standard
food (B) or on food containing 4 mM ZnCl2 (C) or 500 mM CuSO4
(D) Flies expressing Ab42 (E, F) or mutant Ab42 with 3His™Arg
substitutions to abolish metal binding (G, H) were grown on either
standard food (NF) (E, G) or food containing 4 mM Zn (F, H).
Methods: for experiments, food was supplemented to the indicated
concentrations with either CuSO4, ZnCl2, the copper chelator bath-
ocuproinedisulfonate (BCS) disodium salt hydrate (Sigma-Aldrich
No. 14,662-5) or ‘membrane activated chelators’ DP-109 and DP-
460 (D-Pharm, Rehovot) to the indicated concentrations. For sim-
plicity, the ionic metal compounds are in most cases referred to as
zinc (Zn) or copper (Cu).
In every organism, intracellular zinc and copper levels
have to be carefully controlled to avoid starvation or toxic
effects from overload. The zinc finger transcription factor
MTF-1 (metal responsive transcription factor, or metal
response element binding transcription factor), is a key reg-
ulator of heavy metal homeostasis and metal detoxification
from insects to mammals (Radtke et al., 1993; reviewed in
Andrews, 2001; Lichtlen and Schaffner, 2001; Egli et al.,
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Figure 4 Metal chelators ameliorate Ab42-mediated phenotypes.
(A) Survival assay using control flies and Ab42-expressing flies. Ubiquitous expression of Ab42 via actin-Gal4 reduced viability, evident
as a lower eclosure rate (flies completing development to adulthood). The decline in survival was counteracted by supplementation with
the Zn/Cu chelator DP-109 but not by supplementation with BCS chelator which preferentially binds Cu(I). (B–E) Eye sections of 5-day-
old UAS-Ab42-medium/q; GMR-Gal4/q flies raised and kept on food containing 500 mM Cu (B) or 4 mM Zn (C); on food containing
both 500 mM Cu and 250 mM BCS (D), or both 4 mM Zn and 100 mM DP-109 (E). (F) Ab42 expression in the nerve system affects
motoric coordination ability, as measured by a climbing assay with UAS-Ab42 high/elav-Gal4 flies that were raised and kept on standard
food (NF), on food containing 4 mM Zn, or food containing 4 mM Zn in combination with 100 mM chelator DP-460.
Methods: the survival index was calculated based on the eclosure rate of the flies (i.e., flies completing development to adulthood). Flies
that carry a UAS-Ab42S7 transgene were crossed with actin-Gal4/TM3, yq flies on standard food or on food containing either Cu, Zn,
DP-109 or BCS. From the cross, two types of progeny could be obtained, namely, (a) flies that were expressing Ab42 or (b) control flies
that did not express Ab42. The survival index (Is) was calculated as follows: Is 2a/(aqb). For the climbing assay, groups of female flies
were transferred into empty 95=27 mm glass tubes which were marked with a horizontal line 7.5 cm above the bottom. Flies were gently
shaken down to the bottom of the vial and after 10 s the number of flies that had climbed beyond the 7.5 cm mark was recorded. All the
locomotor studies were performed under standardized light conditions. Treatment with MACs does not interfere with the uptake of zinc and
copper in flies (data not shown).
2003; Rutherford and Bird, 2004; Balamurugan and Schaffner,
2006). A major class of MTF-1 target genes encodes metal-
lothioneins, cysteine-rich scavenger proteins for a number of
heavy metals. MTF-1 is also involved in the cellular defense
against other stress conditions, including oxidative stress and
hypoxia. While the lack of MTF-1 renders flies sensitive to
metals, MTF-1 overexpression confers enhanced protection
against heavy metal stress (Balamurugan et al., 2007). Also
in our model system, elevated expression of MTF-1 or of
one of its major target genes, metallothionein A (MtnA),
strongly ameliorated Ab toxicity (Figure 5C, D). Conversely,
in an MTF-1 null mutant background, Ab exerted more
severe damage to the eye tissue (Figure 5B), corroborating
the influence of MTF-1 on the Ab42 phenotype. We also
tested human metallothionein 3 (MT3), the most abundant
metallothionein in the brain, in our system. Indeed the human
MT3 transgene co-expressed with Ab42 suppressed the Ab-
mediated phenotype (Figure 5E). Although it is still unclear
whether reduced levels of metallothioneins, notably of the
brain-enriched MT3, contribute to AD (Uchida et al., 1991;
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Figure 5 MTF-1 and metallothioneins ameliorate Ab42-mediated
eye degeneration.
Shown are eye sections of 5-day-old flies expressing Ab42 alone
(A) or flies co-expressing Ab42 and the key transcription factor for
heavy metal homeostasis and detoxification, MTF-1 of Drosophila
(C) the major Drosophila metallothionein MtnA (D) or human
brain-specific metallothionein MT3 cloned into the pUAST vector
(E) MTF-1, MtnA and human MT3 transgenes were under the reg-
ulation of UAS (upstream activation sequence) promoter. (B) Eye
phenotype of Ab42 expression in flies lacking the metal responsive
regulator MTF-1.
Figure 6 Ab42-expressing flies, but not control flies, are hyper-
sensitive to hydrogen peroxide.
The eyes of control flies (GMR-Gal4/q) displayed no obvious dif-
ference between standard food (A) and food containing 0.025%
H2O2 (B) However, flies expressing Ab42 treated with 0.025%
H2O2 (D) showed stronger eye degeneration than those grown on
standard food (C).
Erickson et al., 1994; Uchida, 1994), our results are consis-
tent with earlier findings that metallothioneins have neuro-
protective functions (Irie and Keung, 2003; Penkowa, 2006;
Meloni et al., 2008; West et al., 2008).
We have previously shown that flies lacking Parkin, a ubi-
quitin ligase involved in Parkinson’s disease, also benefit
from a tight control of copper availability and upregulation
of antioxidant response (Saini et al., 2010). In line with the
findings presented here, elevated expression of MTF-1 dra-
matically improved the condition of the parkin mutant (Saini
et al., 2011). However, unlike the Ab transgenics described
here where extra zinc was at least as bad, if not worse than
copper, zinc supplementation had a strong beneficial effect
on the parkin mutant (Saini and Schaffner, 2010). Taken
together, these findings underline the importance of metals
as modulators in pathogenic processes, notably ones that are
related to human neurodegenerative diseases, but they also
indicate specific requirements depending on the condition.
A large body of evidence indicates that oxidative stress
contributes to AD; for example, patients have higher con-
centrations of oxidative stress markers than age-matched
controls (Markesbery and Lovell, 1998). A previous study
suggested that chelation of copper reduces Ab-mediated
hydrogen peroxide generation and oxidative damage (Huang
et al., 1999). To investigate how oxidative stress affects
Ab42 toxicity, we treated Ab42-expressing flies with hydro-
gen peroxide. We found that at a dosage that does not affect
wild type flies, hydrogen peroxide strongly enhances the eye
degeneration phenotype in Ab42 transgenic flies (Figure 6).
In our Drosophila model, not only zinc excess but also
elevated copper availability enhances the toxicity of Ab. The
latter would be in line with a role of copper in the generation
of ROS by redox cycling, but at variance with some findings
in mammalian systems, where copper is known to be
involved at multiple levels. Copper also binds to APP and
BACE (beta-scretase) and modulates APP processing and
Ab peptide production (Simons et al., 2002; Barnham et al.,
2003; Angeletti et al., 2005). In the brains of AD patients,
copper homeostasis is disturbed, whereby copper is enriched
in the amyloid plaques but its overall level is decreased,
resulting in a reduced Cu/Zn SOD-1 activity (Lovell et al.,
1998). In a transgenic mouse model of AD, dietary copper
restored the function of SOD-1 and reduced plaque forma-
tion (Bayer et al., 2003). This somewhat counter-intuitive
beneficial effect of copper prompted a one-year clinical
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study with copper supplementation (8 mg/day) to patients
with mild AD. This study did not yield conclusive results in
terms of amelioration of cognitive performance but also had
no negative effects (Kessler et al., 2008a,b). Based on the
original idea that copper might exacerbate AD progression,
the metal chelator clioquinol was shown to decrease Ab dep-
osition in Tg2576 transgenic mice (Cherny et al., 2001) and
in a phase II clinical trial was reported to have beneficial
effects. A phase III clinical trial termed PBT2 (see http://
www.alzforum.org/drg/drc/detail.asp?ids110) is under way.
However, even if clioquinol turns out to counteract AD, it
might not act by merely scavenging copper, but rather to
function as a copper carrier to effectively increase intracel-
lular copper levels, as was shown in a yeast model (Treiber
et al., 2004). Thus, while elevated zinc levels promote Ab
aggregation and have adverse effects in vivo, the role of cop-
per remains to be elucidated.
In conclusion, we show that the toxicity of Ab peptides
can be reduced either by chelation of aggregation-promoting
or redox-active metal ions (Zn, Cu), or by reducing oxidative
stress. In addition to metal chelators, we find that expression
of the key regulator of metal homeostasis, MTF-1, or of
human or Drosophila metallothioneins is also capable of
reducing Ab phenotypes. Since MTF-1 is involved in the
defense against several cell stress conditions and is effective
in Drosophila models of Parkinson’s and Alzheimer’s dis-
eases (Saini et al., 2011 and shown here), it would be of
interest to determine if polymorphisms/genetic variations in
MTF-1 gene expression modulate the course of AD and other
human neurodegenerative disorders. Also, further investiga-
tions on metal-ion mediated effects, such as those described
here, are expected to shed more light on the molecular mech-
anisms of AD pathogenesis.
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